Overview

Cilostazol and Endothelial Progenitor Cell

Status:
Active, not recruiting

Trial end date:
2020-07-31

Target enrollment:

Participant gender:

Summary

To assess impact of adjunctive cilostazol on endothelial progenitor cell (EPC) mobilization in patients with acute myocardial infarction (To reveal the role of cilostazol in up-regulation of EPC count)

Phase:

Phase 4

Details

Lead Sponsor:

Gyeongsang National University Hospital

Collaborator:

Korea Otsuka Pharmaceutical Co., Ltd.

Treatments:

Aspirin
Cilostazol
Clopidogrel